Searched for
BIOTECHNOLOGY FIRM PURCHASE
AstraZeneca to buy EsoBiotec for up to $1 billionAstraZeneca is set to acquire biotechnology firm EsoBiotec for up to $1 billion, including a $425 million upfront payment and up to $575 mi...
China mulling probe into Apple's app store fees, practices: ReportThe development comes a day after China announced a wide range of measures targeting US businesses including Google, farm equipment makers ...
China mulling probe into Apple's app store fees, practicesChina's antitrust regulator is preparing for a possible investigation into Apple's app store fees and policies, including its commission on...
Emcure to soon file papers for Rs 4,000 crore IPOThe IPO will consist of a primary issue and offer for sale from its promoter Satish Mehta and existing investor Bain Capital which acquired...
European Union in talks with Moderna, BioNtech, CureVac to secure Covid-19 vaccinesThe talks follow a deal reached in June by four EU states with AstraZeneca for the upfront purchase of 400 million doses of its potential C...
Chinese company sold sub-standard test kits: Spain, CzechSpain, which is the worst affected country after Italy, reportedly found out that rapid coronavirus test kits purchased from a Chinese firm...
Jubilant Life arm inks pact to acquire Inipharm Inc for around USD 28.5 mnDrug firm Jubilant Life Sciences' subsidiary Drug Discovery and Development Solutions Ltd (DDDSL) Singapore has entered into an agreement t...
Domestic pharmaceutical players eye Bharat Serums acquisitionThe two funds together hold a 23% stake and the remainder is with the Daftary family.
RIL, Biocon and YES Bank among top stocks to track todayHere is a list of top stocks that are likely to be in focus in today's trading session.
WHO awards prequalification to Bharat Bio’s Rotavirus vaccineThe vaccine to prevent infant deaths and hospitalisations due to rotavirus diarrhoea was launched by Prime Minister Narendra Modi in March ...
Competition Commission of India clears Wipro-GE India dealCCI has approved medical equipment firm Wipro GE Healthcare's proposed deal to acquire GE group's assets related to bio-technology and life...
A company called ISIS had a massive day on the stock marketAccording to Nasdaq, the stock price of ISIS Pharmaceuticals crossed above its 200-day moving average for the first time since early spring.
A company called ISIS had a massive day on the stock marketISIS Pharmaceuticals, a $4.3 billion biotech firm surged 10% today, and it's up 43% in the last three months.
- Lilliput now gets Rs 120 cr from TPG
Private equity firm TPG has picked a minority stake in children’s apparel and accessories retailer Lilliput Kidswear for Rs 120 crore, a to...
- SEC probes 9 transactions for insider trading violations
Many firms -- Pfizer, Merck, Wyeth, Eli Lilly and Abbott Laboratories, which are under investigation by SEC have significant presence in In...
- Novavax, Cadila form JV for developing vaccines
US-based biotechnology firm Novavax has formed a joint venture with Cadila Pharmaceuticals for developing and commercialising virus-like pa...
- After defence, govt prepares offset policy for other sectors
The government is likely to announce a National Offset Policy, under which foreign vendors would have to procure at least 40% of the contra...
- Biotech cos raise record $9.1 bn venture capital
Venture capitalists pumped a record $9.1 billion into privately-held US biotechnology and medical device companies last year, in hopes of m...
- Fidelity to buy 12-14% stake in Avesthagen
Fidelity Investments is in advanced talks to buy 12-14% stake in the Bangalore-based biotech firm Avesthagen for $10-12 million.
- US firm taps Nasdaq to fund pharma buyouts in India
Trans-India Acquisition Corp, a US-based "blank check" investment firm interested in acquiring pharma companies in India, is tapping the Na...